Epstein-Barr virus (EBV) is the most common cause of infectious mononucleosis (IM), generally known as “mono.” Sometimes referred to as “the kissing disease,” IM occurs primarily in adolescents and young adults. The symptoms of mono can include fever, fatigue, sore throat, and swollen lymph nodes, which can lead to hospitalization.
Meridian is now seeking participants for an investigational mRNA Epstein-Barr Virus vaccine study.
Must be age 18 to 30 and generally healthy
Will receive an investigational EBV vaccine or placebo at no cost
Will receive compensation for study-related time and travel
Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling:
(912) 623-2240(Binghamton, Endwell & Savannah)
(402) 934-7563(Cincinnati, Lincoln & Omaha)
(712) 639-6200(Grand Island, Norfolk & Sioux City)
Submit your information
Savannah: Meridian Clinical Research, 340 Eisenhower Dr #1500, Savannah, GA 31406
Sioux City: Meridian Clinical Research, 4802 Sunnybrook Dr., Sioux City, IA 51106
Norfolk: Meridian Clinical Research, 1410 N 13th St, Suite 5, Norfolk, NE 68701
Omaha: Meridian Clinical Research, 3319 N 107th St, Omaha, NE 68134
Lincoln: Meridian Clinical Research, 4600 Valley Rd., Lincoln, NE 68510
Grand Island: Meridian Clinical Research, 3537 West 13th St., Ste. 100, Grand Island, NE 68803
Binghamton: Meridian Clinical Research, 1290 Upper Front Street, Binghamton, NY 13901
Endwell: Meridian Clinical Research, 3319 N 107th St, Omaha, NE 68134
After you submit your information, a Meridian enrollment specialist will contact you.
Participating in a study is an important decision — we’re here to help you before, during, and after studies.
Please note: Health insurance is NOT required to join.
Will I benefit from this study?
You are not guaranteed to benefit from being in a clinical study. However, information gathered in this study may help prevent EBV for you and others worldwide.
Is participation voluntary after I submit my information?
Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the vaccine being studied, your role in the trial, potential side effects, tests that will be performed, and the number of visits required. You will need to sign an informed consent form to join the study only after you fully understand your role in the study.
Will I get a physical exam?
If you join the study, you will receive a physical exam. You may also receive specific exams or tests — the results of which may be shared with you.
Will I receive compensation?
While participation in a clinical study is voluntary, you may be reimbursed for your study-related travel expenses. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible reimbursement with you.
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.